.....Advertisement.....

Biocon's Itolizumab approved as life-saving COVID-19 medicine; Kiran Mazumdar-Shaw announces details

Kiran Mazumdar Shaw, Executive Chairperson of Biocon Limited, Bengaluru, announced Monday that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb) Injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) patients due to COVID-19.

from IndiaTV India: Google News Feed https://ift.tt/2AXg6ai

Get Breaking news, Live news, and latest news from India and around the world on INDILIVENEWS.com, which are in the interest of nation and humanity. Like us on Facebook or Follow us on Twitter and Reddit for the latest news blog and live news update

Trending News

Loading...